CIK 0001279704
- Non-accelerated filer
- Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043321804
- Phone
- +1 608-441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-04-20 | NEIS JOHN Director | Purchase | +234,742 | $2.12 | $498K | 297,984 |
| 2016-04-20 | NEIS JOHN Director | Purchase · Series A Warrants | +234,742 | $0.01 | $2K | 274,613 |
| 2015-06-09 | NEIS JOHN Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2015-02-26 | NEIS JOHN Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2014-08-20 | NEIS JOHN Director | Purchase | +130,000 | $3.75 | $488K | 493,715 |
| 2014-08-20 | NEIS JOHN Director | Purchase | +138,711 | $3.75 | $520K | 632,426 |
| 2014-08-20 | NEIS JOHN Director | Purchase · Stock Purchase Warrant (right to buy) | +130,000 | $0.01 | $1K | 130,000 |
| 2014-08-20 | NEIS JOHN Director | Sale · Convertible Debenture (right to buy) | −50,000 | $3.75 | $188K | 0 |
| 2014-08-20 | NEIS JOHN Director | Purchase · Stock Purchase Warrant (right to buy) | +138,711 | $0.01 | $1K | 268,711 |
Page 2 of 2 · 29 trades